Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: A randomised controlled trial
- PMID: 28463759
- DOI: 10.1016/j.ejca.2017.03.038
Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: A randomised controlled trial
Abstract
Purpose: To investigate if robot-assisted laparoscopic surgery (RALS) was non-inferior to laparotomy (LT) in harvesting infrarenal paraaortic lymph nodes in patients with presumed stage I-II high-risk endometrial cancer.
Patients and methods: Patients with histologically proven endometrial cancer, presumed stage I-II with high-risk tumour features, were randomised to hysterectomy, bilateral salpingo-oophorectomy, pelvic and paraaortic lymphadenectomy by either RALS or LT. Primary outcome was paraaortic lymph node count. Secondary outcomes were perioperative events, postoperative complications and total health care cost.
Results: Overall 120 patients were randomised and 96 patients were included in the per protocol analysis. Demographic, clinical and tumour characteristics were evenly distributed between groups. Mean (±SD) paraaortic lymph node count was 20.9 (±9.6) for RALS and 22 (±11, p = 0.45) for LT. The difference of means was within the non-inferiority margin (-1.6, 95% CI -5.78, 2.57). Mean pelvic node count was lower after RALS (28 ± 10 versus 22 ± 8, p < 0.001). There was no difference in perioperative complications or readmissions between the groups. Operation time was longer (p < 0.001) but total blood loss less (<0.001) and hospital stay shorter (<0.001) in RALS group than LT group. Health care costs for RALS was significantly lower (mean difference $1568 USD/€1225 Euro, p < 0.05).
Conclusion: Our results demonstrate non-inferiority in paraaortic lymph node count, comparable complication rates, shorter hospital length and lower total cost for RALS over laparotomy. Generalisability of the latter finding requires a high-volume setting and high surgical proficiency. In women with high-risk endometrial cancer confined to the uterus, RALS is a valid treatment modality.
Clinical trials registrations: ClinicalTrials.govNCT01847703.
Keywords: Endometrial cancer; Laparotomy; Lymph node count; Paraaortic lymphadenectomy; Robotic surgery.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Learning curve and surgical outcome for robotic-assisted hysterectomy with lymphadenectomy: case-matched controlled comparison with laparoscopy and laparotomy for treatment of endometrial cancer.J Minim Invasive Gynecol. 2010 Nov-Dec;17(6):739-48. doi: 10.1016/j.jmig.2010.07.008. J Minim Invasive Gynecol. 2010. PMID: 20955983
-
Long-term quality of life after comprehensive surgical staging of high-risk endometrial cancer - results from the RASHEC trial.Acta Oncol. 2018 Dec;57(12):1671-1676. doi: 10.1080/0284186X.2018.1521987. Epub 2018 Oct 5. Acta Oncol. 2018. PMID: 30289327 Clinical Trial.
-
Robotic-assisted vs traditional laparoscopic surgery for endometrial cancer: a randomized controlled trial.Am J Obstet Gynecol. 2016 Nov;215(5):588.e1-588.e7. doi: 10.1016/j.ajog.2016.06.005. Epub 2016 Jun 8. Am J Obstet Gynecol. 2016. PMID: 27288987 Clinical Trial.
-
Robotic paraaortic lymphadenectomy in oncogynecology. Double side docking of daVinci S system increases the success rates of high paraaortic lymph node dissection in endometrial cancer.Ceska Gynekol. 2019 Winter;84(1):4-17. Ceska Gynekol. 2019. PMID: 31213052 Review. English.
-
Robot-assisted versus conventional laparoscopic surgery for endometrial cancer staging: A meta-analysis.Taiwan J Obstet Gynecol. 2016 Aug;55(4):488-94. doi: 10.1016/j.tjog.2016.01.003. Taiwan J Obstet Gynecol. 2016. PMID: 27590368 Review.
Cited by
-
Oncologic and Operative Outcomes of Robotic Staging Surgery Using Low Pelvic Port Placement in High-Risk Endometrial Cancer.Curr Oncol. 2024 Dec 5;31(12):7820-7827. doi: 10.3390/curroncol31120576. Curr Oncol. 2024. PMID: 39727699 Free PMC article.
-
Nationwide Comparison of Surgical and Oncologic Outcomes in Endometrial Cancer Patients Undergoing Robotic, Laparoscopic, and Open Surgery: A Population-Based Cohort Study.Cancer Res Treat. 2021 Apr;53(2):549-557. doi: 10.4143/crt.2020.802. Epub 2020 Oct 22. Cancer Res Treat. 2021. PMID: 33091967 Free PMC article.
-
Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study.J Cancer Res Clin Oncol. 2021 Mar;147(3):845-852. doi: 10.1007/s00432-020-03372-x. Epub 2020 Sep 3. J Cancer Res Clin Oncol. 2021. PMID: 32880752 Free PMC article.
-
Prognosis and Efficacy of Laparoscopic Surgery on Patients with Endometrial Carcinoma: Systematic Evaluation and Meta-Analysis.Comput Math Methods Med. 2022 Sep 22;2022:9384134. doi: 10.1155/2022/9384134. eCollection 2022. Comput Math Methods Med. 2022. PMID: 36238475 Free PMC article.
-
Robotic-Assisted Pelvic Lymphadenectomy for Metastatic Melanoma Results in Durable Oncologic Outcomes.Ann Surg Oncol. 2020 Jan;27(1):196-202. doi: 10.1245/s10434-019-07333-8. Epub 2019 Apr 4. Ann Surg Oncol. 2020. PMID: 30949862 Free PMC article.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical